Medication non-adherence stands as one of the most persistent and costly challenges in modern healthcare, contributing to over $100 billion in avoidable medical spending each year and leading to preventable health crises for patients with chronic conditions. In a bold move to confront this issue,
The audacious plan to dismantle and rebuild foundational elements of the American healthcare system was unveiled not from a traditional policy forum, but from the high-powered stage of the J.P. Morgan Healthcare Conference, signaling a seismic shift in how Washington intends to engage with the
Health systems across many low- and middle-income countries are straining under the weight of persistent challenges, including critical workforce shortages, fragmented service delivery, and inadequate data systems that limit access to care and perpetuate inequities in health outcomes. These issues
The U.S. Food and Drug Administration has dramatically reshaped the future of personal health technology by rolling out significant updates to its regulatory framework for consumer wearables and artificial intelligence-powered software. Announced by FDA Commissioner Marty Makary, M.D., during the
The dawn of a new year has brought with it a significant realignment of leadership across the American healthcare sector, as a cascade of executive appointments and retirements redefines the strategic direction of major health systems, technology innovators, and influential advocacy organizations.
Navigating the fragmented landscape of personal health information, from disparate lab results and doctor's notes to daily fitness tracker data, has long been a significant challenge for individuals seeking a comprehensive understanding of their own well-being. In response to this growing need for
